GRIMES & COMPANY, INC. Ironwood Pharmaceuticals, Inc. Transaction History

GRIMES & COMPANY, INC. portfolio value:

$496,000
portfolio value

GRIMES & COMPANY, INC. quarter portfolio value change:

-10.15%
quarter

Ironwood Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +2.47% 1.15K shares -42K $10.36 47.84K
Q2 2022 share Decrease -11.60% -6.12K shares -126K $11.53 46.69K
Q1 2022 share Increase +9.73% 4.68K shares 103K $12.58 52.81K
Q4 2021 share Increase +0.02% 12 shares -67K $11.7 48.13K
Q3 2021 share Increase +6.46% 2.92K shares 46K $13.06 48.12K
Q2 2021 share Increase +11.60% 4.69K shares 129K $12.87 45.19K
Q1 2021 share Increase +189.15% 26.49K shares 293K $11.18 40.50K
Q4 2020 share 0.00% 0 shares 34K $11.39 14.00K
Q3 2020 share Increase +23.03% 2.62K shares 9K $9 14.00K
Q2 2020 share Decrease -33.42% -5.71K shares -56K $10.32 11.38K
Q1 2020 share 0.00% 0 shares -55K $10.09 17.1K
Q4 2019 share 0.00% 0 shares 81K $13.31 17.1K
Q3 2019 share Increase 0.00% 17.1K shares 147K $8.59 17.1K